Capricor Therapeutics (CAPR) Shareholder's Equity (2010 - 2026)

Capricor Therapeutics (CAPR) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 Capricor Therapeutics 1.53 Bn 1.26 Bn - 278.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 278.70 Mn
Dec 31, 2025 305.79 Mn
Sep 30, 2025 83.87 Mn
Jun 30, 2025 104.98 Mn
Mar 31, 2025 127.65 Mn
Dec 31, 2024 145.46 Mn
Sep 30, 2024 68.26 Mn
Jun 30, 2024 11.50 Mn
Mar 31, 2024 18.43 Mn
Dec 31, 2023 22.60 Mn
Sep 30, 2023 -1.79 Mn
Jun 30, 2023 2.73 Mn
Mar 31, 2023 6.21 Mn
Dec 31, 2022 11.79 Mn
Sep 30, 2022 15.43 Mn
Jun 30, 2022 18.73 Mn
Mar 31, 2022 24.64 Mn
Dec 31, 2021 31.37 Mn
Sep 30, 2021 36.74 Mn
Jun 30, 2021 33.38 Mn